ArticleHuman vaccines & immunotherapeutics2024

First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?

Dimitrios Bouzianas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.